BridgeBio Pharma, Inc. Uncategorized Contracts & Agreements

19 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Second Amendment, effective as of August 15, 2023, to the Exclusive (Equity) Agreement, by and between Eidos Therapeutics, Inc. and the Board of Trustees of the Leland Stanford...
BridgeBio Pharma, Inc.
Biotechnology
2023
Description of Securities
BridgeBio Pharma, Inc.
Biotechnology
DE
2022
Description of Securities
BridgeBio Pharma, Inc.
Biotechnology
DE
2021
Form of Confirmation for Capped Call Transactions
BridgeBio Pharma, Inc.
Biotechnology
DE
2021
Form of Confirmation for Capped Call Transactions
BridgeBio Pharma, Inc.
Biotechnology
2020
Offer Letter, between BridgeBio Pharma, Inc. and James C. Momtazee, dated February 23, 2020
BridgeBio Pharma, Inc.
Biotechnology
2020
Description of Securities
BridgeBio Pharma, Inc.
Biotechnology
DE
2020
Offer Letter, between and BridgeBio Services, Inc. and Yi Ching Yau, dated September 9, 2019
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Pharma, Inc. and Brian Stolz, dated September 19, 2019
BridgeBio Pharma, Inc.
Biotechnology
2019
Form of Tax Sharing Agreement, between the Registrant and each of its subsidiaries
BridgeBio Pharma, Inc.
Biotechnology
DE
2019
Offer Letter, between Eidos Therapeutics, Inc. and Cameron Turtle, dated June 13, 2018
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Cameron Turtle, dated December 13, 2016, as amended on May 5, 2017
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Michael Henderson, dated March 22, 2016, as amended on May 5, 2017
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Richard Scheller, dated April 5, 2019
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Charles Homcy, dated February 20, 2019
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between Eidos Therapeutics, Inc. and Uma Sinha, dated June 1, 2016, as amended on May 24, 2018
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Brian Stephenson, dated October 28, 2018
BridgeBio Pharma, Inc.
Biotechnology
2019
Offer Letter, between BridgeBio Services, Inc. and Neil Kumar, dated December 14, 2017
BridgeBio Pharma, Inc.
Biotechnology
2019
Exclusive (Equity) Agreement, by and between Eidos Therapeutics, Inc. and the Board of Trustees of the Leland Stanford Junior University, effective as of April 10, 2016, as...
BridgeBio Pharma, Inc.
Biotechnology
CA
2019